CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,080 | $498.45 | $1.0M | 331,863 |
| 2026-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,220 | $499.15 | $609K | 330,643 |
| 2026-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −492 | $500.19 | $246K | 330,151 |
| 2026-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −708 | $501.52 | $355K | 329,443 |
| 2026-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,160 | $502.44 | $1.1M | 327,283 |
| 2026-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,538 | $503.53 | $774K | 325,745 |
| 2026-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,182 | $504.17 | $596K | 324,563 |
| 2026-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $505.20 | $61K | 324,443 |
| 2026-09-16 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 423,410 | ||
| 2026-09-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −780 | $499.77 | $390K | 333,163 |
| 2026-09-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,711 | $500.68 | $1.9M | 329,452 |
| 2026-09-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,689 | $501.66 | $1.3M | 326,763 |
| 2026-09-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −825 | $502.57 | $415K | 325,938 |
| 2026-09-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −845 | $503.80 | $426K | 325,093 |
| 2026-09-15 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −650 | $504.57 | $328K | 324,443 |
| 2026-09-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 432,910 | ||
| 2026-09-14 | Mesa Nilda Director | Option exercise | +130 | $110.86 | $14K | 6,560 |
| 2026-09-14 | Mesa Nilda Director | Sale | −130 | $505.79 | $66K | 6,430 |
Page 36 of 121 · 2,404 trades